Navigation Links
Trials for new drug to overcome HIV

A new drug that could help overcome HIV�fs growing resistance to existing antiviral drugs is about to be tested in combination with standard antivirals. Called PA-457, it is the first of a new class of anti-HIV compounds called maturation inhibitors. The drug is still in its early stages, and will not be generally available for at least three years.

Up to 80 per cent of HIV positive people on treatment show resistance to one or more of their drugs, according to Graham Allaway of Panacos Pharmaceuticals in Gaithersburg, Maryland, which is developing PA-457. Panacos hopes to begin trials this month to test how well the drug works in patients whose existing drug regimes are failing.

PA-457 aims to overcome this resistance by attacking HIV on new front. Many existing drugs work by blocking reverse transcriptase, an enzyme that enables HIV to replicate within cell. Others disable protease, which helps to assemble the virus into particles that infect other cells.

Recent experiments in collaboration with Michael Sakalian and his colleagues at the University of Oklahoma Health Sciences Center in Oklahoma City have shown that PA-457 works in a different way. It attacks HIV by disrupting formation of a conical shield, called the capsid protein, which stores and protects the RNA heart of the HIV particles as they bud out from infected cells.

The latest research, in which the virus was examined under a microscope, shows that the drug binds to the capsid protein at acrucial stage in its manufacture (Journal of Virology, vol 80, p 5716). Normally, the capsid protein is clipped apart from a major structural protein called the gag protein, and is then assembled into a cone. PA-457 stops it being clipped off, causing it to form a leaky sphere that leaves the core RNA exposed (see Diagram, left). This cripples the virus, preventing it from infecting any other cells once it buds out from the host.

Previous lab experiments on infected human cells
'"/>

Source:New Scientist


Page: 1 2

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Trials for new drug overcome HIV

(Date:11/5/2009)... has been awarded a training grant in the amount o...der its Integrative Graduation Education and Resea...ERT grant to be awarded to Kent State. The grant, ...investment Act of 2009, runs through 2014. , The...ronment aquatic resource sensing (EARS). The purpo...
(Date:11/4/2009)... bacteria, it turns out, hold the power to help mi... the world clean up toxic waste on test sites. , ...were invented back in World War II and have been u...-energy compounds are often used to propel tank sh... , But with increased knowledge of their enviro...
(Date:11/4/2009)...if., Oct. 20 DigitalPersona, Inc.,...on solutions, today announced that WAND Corporatio...are for quick-service restaurants, has integrated ...nd Classic POS solutions. WAND,s quick-service cus... cashier accountability and deter unauthorized man...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Anemic Patients With MDS Gain Long Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones 5017 1Anemic Patients With MDS Gain Long Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones 5017 2Anemic Patients With MDS Gain Long Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones 5017 3Anemic Patients With MDS Gain Long Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones 5017 4Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 1Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 2Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 3Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 1Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 2Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 3
... Karen Christman, an assistant bioengineering prof...ring, plans to help fuel the growing field of tiss...tor Award grant from the National Institutes of He.... , The awards, announced Sept. 22, were created ...tors who have exceptional creativity and propose b...
...omising finding for the field of regenerative medi... of Pittsburgh of UPMC have identified a source of...els with the unlimited potential to differentiate ...cle. , The scientists, led by Bruno Pault, PhD, d... Children,s Hospital, identified cells known as pe...
...ds, the first four-legged land animals, are regard...s. Now researchers at Uppsala University can show...ound rudiments of fingers in the fins in fossil Pa...tes that rudimentary fingers developed considerabl... ancestors evolved into the first four-legged anim...
Other Biology News:Generation innovation: Young UC San Diego bioengineer to use NIH grant to fuel tissue engineering 2Generation innovation: Young UC San Diego bioengineer to use NIH grant to fuel tissue engineering 3Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential 2Primordial fish had rudimentary fingers 2
(Date:11/6/2009)...Arrowhead’s 2010 Personalized Medicine Partn...February 22-24, 2010 in Philadelphia, has been ann...ight key issues in forming partnerships and engage... Minneapolis, MN (PRWEB) No... 2010 Personalized Medicine Partnerships Conferen...
(Date:11/5/2009)...Call/ -- Imagenetix, Inc. (OTC Bulletin Board: IAG...t and CEO of Imagenetix, will be presenting the Co...e on Thursday, December 3rd, at 10:30 AM PST at th... ,, LD MICRO is a by-invitation only newsletter...s in the micro-cap space. Since 2002, the firm has...
(Date:11/5/2009)...re-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today an...e following investor conferences, and invited inve... Credit Suisse Healthcare Conference, Phoenix, ... 10 a.m. Mountain Time, NASDAQ OM... Tuesday, 1 December, 2009 at 10.45 a.m. Gr...
(Date:11/5/2009)...PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corpora...any") today announced,that the Company plans to re...ay, November 9, 2009, after the market closes. ,... 5:00 pm ET on November 9, 2009,to discuss third q...l by,dialing 1-888-713-4211 or 1-617-213-4864 for ...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...p with the team at Qurb (pronounced "curb"), I hav...other anti-spam product. Not that the spam problem...th dozens of products and services in the market, ... start-up. This start-up, though, was different. ...re just building what was to become AvantGo. Felix...
...rformance ,Todays business conditions provide a g...hile the battles for talent might appear to have c...ho move beyond battlefield tactics to long-term wi...s from making a clear choice in your overall talen...management practice to that choice, even when the ...
... rank high in national survey by InformationWeek ... businesses to ever-higher efficiency is better us... it is enterprise resource planning (ERP) software...ng software, IT is the vice that squeezes producti...on on the most recent InformationWeek 500 list of ...
Other Biology Technology:Qurb Gets a Step Up From Second-Time Entrepreneurs 2Qurb Gets a Step Up From Second-Time Entrepreneurs 3Qurb Gets a Step Up From Second-Time Entrepreneurs 4Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3Wisconsins Business IT Innovators 2
VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences
...S and ES1301 mutS are mismatch repair minus strain... of the newly synthesized unmethylated strand (1),...them helpful in such systems as the GeneEditor and... and BMH 71-18 mutS are recA+, therefore inserts c...
Rat IFN-gamma ELISpot Development Kit from R&D Systems
Mouse Anti-Rat KAPPA / LAMBDA Monoclonal Antibody, Horseradish Peroxidase Conjugated, Clone MARK-1 / MARL-15 from Cell Sciences
Biology Products: